Product Name
5-MeO-MiPT Freebase
Chemical Formula
C15H22N2O2
CAS Number
96096-55-8
Description
5-MeO-MiPT, also known as Moxy, is a research chemical belonging to the tryptamine family. This compound is primarily used in scientific studies to explore its psychoactive effects. The freebase form allows for versatile applications in research.
Purity Level
5-MeO-MiPT Freebase has a purity greater than 97%, ensuring reliable results for research applications.
Appearance
The product typically appears as an off-white to white powder.
Packaging Options
5-MeO-MiPT Freebase is available in the following quantities:
- 250mg
- 500mg
Storage Instructions
To maintain the integrity of 5-MeO-MiPT Freebase, store it in a cool, dry place away from direct sunlight and moisture. Ensure that the container is tightly sealed.
Safety Information
When handling 5-MeO-MiPT Freebase, it is essential to follow proper safety protocols. Use gloves and protective eyewear, and work in a well-ventilated area. This product is intended for research purposes only and should not be ingested or inhaled. Always comply with local regulations regarding the use and disposal of research chemicals.
Shipping Information
We provide free tracked shipping for all orders. 5-MeO-MiPT Freebase is shipped discreetly from our facilities in the Netherlands, ensuring secure and timely delivery worldwide. Typical delivery times range from 3-7 business days, depending on the destination.
Pricing
- 250mg: €37.00
- 500mg: €62.00
FAQs
Q: What is the main use of 5-MeO-MiPT Freebase?
A: 5-MeO-MiPT Freebase is intended for research purposes to study its psychoactive effects.
Q: Is 5-MeO-MiPT Freebase safe for human consumption?
A: No, this product is not meant for human consumption and should be handled with caution.
Q: What payment methods do you accept?
A: We accept Bitcoin, Revolut, wire transfer, CashApp, and PayPal.
Contact Information
For further inquiries or assistance, please contact our customer service team via email at [email protected] or visit our Contact Us page.
